Investor Conference Attendance

AI SummaryClose X

TheraCryf will present its lead Ox-1 addiction programme at investor events in London, with the CEO speaking at the LSX Investival Showcase on 16 November 2026 at 11:45 and at Mello London on 17 November 2026 (10:40–11:10) and 18 November 2026 (14:25–14:55); management will meet existing and prospective investors and notes it met potential partners at BIO‑Europe on 9–11 November 2026. The company confirms the presentations will draw only on publicly available information and that no new material information will be disclosed.

Disclaimer*

UK 100